MR imaging and spectroscopy of a tuber cinereum hamartoma in a patient with growth hormone deficiency and hypogonadotropic hypogonadism

American Journal of Neuroradiology

Volumn 24, Issue 6, 2003, Pages 1177-1180

  Martin, David D ^a   Seeger, Uwe ^a   Ranke, Michael B ^a   Grodd, Wolfgang ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL; N ACETYLASPARTIC ACID;

ADOLESCENT; AMYGDALOID NUCLEUS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; GROWTH HORMONE DEFICIENCY; HAMARTOMA; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSTERIOR HYPOTHALAMUS; THALAMUS;

ADOLESCENT; AMYGDALA; ASPARTIC ACID; CHOLINE; CREATINE; DIAGNOSIS, DIFFERENTIAL; GONADOTROPINS, PITUITARY; HAMARTOMA; HUMAN GROWTH HORMONE; HUMANS; HYPOGONADISM; HYPOTHALAMIC DISEASES; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; THALAMUS; TUBER CINEREUM;

EID: 0038614737     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Sturm JW, Andermann F, Berkovic SF. "Pressure to laugh": an unusual epileptic symptom associated with small hypothalamic hamartomas. Neurology 2000;54:971-973
2. Arita K, Ikawa F, Kurisu K, et al. The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma. J Neurosurg 1999;91:212-220
3. Demaerel P, Johannik K, Van H, et al. Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 15:67-76
4. Pascual C, Moneo JH, Viano J, et al. [Hypothalamic hamartomas: control of seizures after partial removal in one case]. Rev Neurol 2000;31:119-122
5. Tasch E, Cendes F, Li LM, et al. Hypothalamic hamartomas and gelastic epilepsy: a spectroscopic study. Neurology 1998;51:1046-1050
6. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679
7. Seeger U, Mader I, Klose U, et al. Parametrized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn Reson Med 2003;49:19-28
8. Mahachoklertwattana P, Kaplan SL, Grumbach MM. The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab 1993;77:118-124
9. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994;10:191-247
10. Hüppi P, Fusch C, Boesch C, et al. Regional metabolic assessment of human brain during development by proton magnetic resonance spectroscopy in vivo and by high-performance liquid chromatography/gas chromatography in autopsy tissue. Pediatr Res 1995;37: 145-150
11. Ross BD. Biochemical considerations in 1H spectroscopy: glutamate and glutamine: myo-inositol and related metabolites. NMR Biomed 1991;4:59-63